A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer.

Scientists at UC San Francisco have just conducted the first-in-human Phase I study of CTT1057 in patients with localized and metastatic prostate cancer. CTT1057 is a lead diagnostic product from Cancer Targeted Technology (CTT), sponsor of this clinical trial, a collaboration between the Department of Radiology and Biomedical Imaging, Hematology/Oncology, Pathology and Urology. This important work was recently published online in The Journal of Nuclear Medicine.

UCSF Radiology is excited to announce that our Interventional Radiology Clinic at UCSF Health Parnassus campus now has a new home.

A cancer diagnosis can be terrifying news. Azela’s story is one that emphasizes the importance of both genetic cancer testing and family ties.

The Precision Imaging of Cancer & Therapy (PICT) Program has announced the date, time and location of their Annual Retreat. It will take place on January 23, 2019 from 12 pm – 6 pm at the Presidio Officers' Club located on 50 Moraga Ave in San Francisco, CA.

With complimentary backgrounds in basic and clinical neuroscience and a shared desire to ask (and answer) big questions, when Drs. Desikan and Sugrue met in the Neuroradiology fellowship training program at UCSF they quickly became both friends and research partners. Today as junior faculty in the Department of Radiology and Biomedical Imaging they jointly run the Laboratory for Precision Neuroimaging at UCSF.